主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识

2021-12-26 中华预防医学会疫苗与免疫分会 中国疫苗和免疫

慢性病严重威胁中国居民健康。与健康人群相比,慢性病人群患流感和侵袭性肺炎球菌性疾病的几率增加,可加重原有慢性病,导致慢性病人群死亡率增高。

中文标题:

主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识

发布日期:

2021-12-26

简要介绍:

慢性病严重威胁中国居民健康。与健康人群相比,慢性病人群患流感和侵袭性肺炎球菌性疾病的几率增加,可加重原有慢性病,导致慢性病人群死亡率增高。流感疫苗和肺炎球菌疫苗接种可减少慢性病人群发生呼吸道感染和严重并发症的机会,降低住院和死亡,减轻疾病负担。本共识基于国内外现有的研究证据,介绍了中国主要慢性病疾病负担、主要慢性病人群罹患流感和肺炎球菌性疾病的疾病负担、接种流感疫苗和肺炎球菌疫苗的保护效果和安全性、疫苗接种建议等内容,旨在为疾病预防控制机构和相关医疗机构开展应用疫苗防控慢性病人群感染性疾病工作提供参考。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c2d701c002326598, title=主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识, enTitle=, guiderFrom=中国疫苗和免疫, authorId=0, author=, summary=慢性病严重威胁中国居民健康。与健康人群相比,慢性病人群患流感和侵袭性肺炎球菌性疾病的几率增加,可加重原有慢性病,导致慢性病人群死亡率增高。, cover=https://img.medsci.cn/2022118/1642517789144_5579292.jpg, journalId=0, articlesId=null, associationId=2316, associationName=中华预防医学会疫苗与免疫分会, associationIntro=中华预防医学会疫苗与免疫分会, copyright=0, guiderPublishedTime=Sun Dec 26 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">慢性病严重威胁中国居民健康。与健康人群相比,慢性病人群患流感和侵袭性肺炎球菌性疾病的几率增加,可加重原有慢性病,导致慢性病人群死亡率增高。流感疫苗和肺炎球菌疫苗接种可减少慢性病人群发生呼吸道感染和严重并发症的机会,降低住院和死亡,减轻疾病负担。本共识基于国内外现有的研究证据,介绍了中国主要慢性病疾病负担、主要慢性病人群罹患流感和肺炎球菌性疾病的疾病负担、接种流感疫苗和肺炎球菌疫苗的保护效果和安全性、疫苗接种建议等内容,旨在为疾病预防控制机构和相关医疗机构开展应用疫苗防控慢性病人群感染性疾病工作提供参考。&nbsp;</span></p>, tagList=[TagDto(tagId=3812, tagName=流感疫苗), TagDto(tagId=36600, tagName=肺炎球菌疫苗), TagDto(tagId=117468, tagName=感染病病毒组)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5034, appHits=60, showAppHits=0, pcHits=538, showPcHits=4974, likes=0, shares=14, comments=5, approvalStatus=1, publishedTime=Tue Jan 18 22:51:18 CST 2022, publishedTimeString=2021-12-26, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Jan 18 22:54:40 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 13:51:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识.pdf)])
主要慢性病人群流感疫苗和肺炎球菌疫苗接种专家共识.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241747, encodeId=f49b1241e476b, content=<a href='/topic/show?id=76456533481' target=_blank style='color:#2F92EE;'>#流感疫苗#</a>和<a href='/topic/show?id=48918218088' target=_blank style='color:#2F92EE;'>#肺炎球菌疫苗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65334, encryptionId=76456533481, topicName=流感疫苗), TopicDto(id=82180, encryptionId=48918218088, topicName=肺炎球菌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:05:48 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217569, encodeId=5ce7121e569a5, content=学习获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22915533438, createdName=ms1000000205631438, createdTime=Sat May 07 10:23:45 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215198, encodeId=133c1215198e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Thu Apr 28 00:30:44 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186519, encodeId=3d761186519cf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44596396741, createdName=ms6000000972352946, createdTime=Thu Jan 20 17:58:08 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185873, encodeId=b1c111858e3f0, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:29:10 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1241747, encodeId=f49b1241e476b, content=<a href='/topic/show?id=76456533481' target=_blank style='color:#2F92EE;'>#流感疫苗#</a>和<a href='/topic/show?id=48918218088' target=_blank style='color:#2F92EE;'>#肺炎球菌疫苗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65334, encryptionId=76456533481, topicName=流感疫苗), TopicDto(id=82180, encryptionId=48918218088, topicName=肺炎球菌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:05:48 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217569, encodeId=5ce7121e569a5, content=学习获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22915533438, createdName=ms1000000205631438, createdTime=Sat May 07 10:23:45 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215198, encodeId=133c1215198e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Thu Apr 28 00:30:44 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186519, encodeId=3d761186519cf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44596396741, createdName=ms6000000972352946, createdTime=Thu Jan 20 17:58:08 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185873, encodeId=b1c111858e3f0, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:29:10 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-05-07 ms1000000205631438

    学习获益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241747, encodeId=f49b1241e476b, content=<a href='/topic/show?id=76456533481' target=_blank style='color:#2F92EE;'>#流感疫苗#</a>和<a href='/topic/show?id=48918218088' target=_blank style='color:#2F92EE;'>#肺炎球菌疫苗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65334, encryptionId=76456533481, topicName=流感疫苗), TopicDto(id=82180, encryptionId=48918218088, topicName=肺炎球菌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:05:48 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217569, encodeId=5ce7121e569a5, content=学习获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22915533438, createdName=ms1000000205631438, createdTime=Sat May 07 10:23:45 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215198, encodeId=133c1215198e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Thu Apr 28 00:30:44 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186519, encodeId=3d761186519cf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44596396741, createdName=ms6000000972352946, createdTime=Thu Jan 20 17:58:08 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185873, encodeId=b1c111858e3f0, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:29:10 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-04-28 红土豆瓣酱

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241747, encodeId=f49b1241e476b, content=<a href='/topic/show?id=76456533481' target=_blank style='color:#2F92EE;'>#流感疫苗#</a>和<a href='/topic/show?id=48918218088' target=_blank style='color:#2F92EE;'>#肺炎球菌疫苗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65334, encryptionId=76456533481, topicName=流感疫苗), TopicDto(id=82180, encryptionId=48918218088, topicName=肺炎球菌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:05:48 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217569, encodeId=5ce7121e569a5, content=学习获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22915533438, createdName=ms1000000205631438, createdTime=Sat May 07 10:23:45 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215198, encodeId=133c1215198e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Thu Apr 28 00:30:44 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186519, encodeId=3d761186519cf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44596396741, createdName=ms6000000972352946, createdTime=Thu Jan 20 17:58:08 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185873, encodeId=b1c111858e3f0, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:29:10 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-20 ms6000000972352946

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241747, encodeId=f49b1241e476b, content=<a href='/topic/show?id=76456533481' target=_blank style='color:#2F92EE;'>#流感疫苗#</a>和<a href='/topic/show?id=48918218088' target=_blank style='color:#2F92EE;'>#肺炎球菌疫苗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65334, encryptionId=76456533481, topicName=流感疫苗), TopicDto(id=82180, encryptionId=48918218088, topicName=肺炎球菌疫苗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=循证小兵, createdTime=Mon Aug 29 03:05:48 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1217569, encodeId=5ce7121e569a5, content=学习获益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22915533438, createdName=ms1000000205631438, createdTime=Sat May 07 10:23:45 CST 2022, time=2022-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215198, encodeId=133c1215198e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31135620079, createdName=红土豆瓣酱, createdTime=Thu Apr 28 00:30:44 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186519, encodeId=3d761186519cf, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44596396741, createdName=ms6000000972352946, createdTime=Thu Jan 20 17:58:08 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185873, encodeId=b1c111858e3f0, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Jan 19 07:29:10 CST 2022, time=2022-01-19, status=1, ipAttribution=)]
    2022-01-19 微探

    学习学习

    0